A 5-year-old boy is brought to your pediatric clinic by his mother with a chief complaint of fever, rash, and joint pain. He was prescribed cefaclor (oral cephalosporin) for acute otitis media 10 days ago. He took the medication for 8 days. Yesterday, he developed fever (38.9Β°C), an urticarial rash on his trunk and extremities, and swelling and pain in his knees and ankles. He is otherwise well-appearing but irritable. On examination, he has generalized urticarial wheals, mild swelling of both knees, tenderness on palpation of the knees and ankles, and small, non-tender cervical lymph nodes. His throat is clear, conjunctivae normal, and there is no oral mucosal involvement. The mother is very anxious and asks: "Could this be an allergic reaction to the antibiotic? Is this serious? What should we do?"
Task for the candidate: You are the pediatrician. Discuss your approach to this patient. Identify the most likely diagnosis (serum sickness-like reaction [SSLR] or serum sickness). Differentiate from other conditions (Kawasaki disease, juvenile idiopathic arthritis, urticarial vasculitis, viral exanthem). Describe the pathophysiology (type III hypersensitivity β immune complex deposition). Outline the management: (1) discontinue the offending drug (cefaclor), (2) symptomatic treatment (antihistamines for urticaria, NSAIDs for arthralgias), (3) corticosteroids for severe cases, (4) avoidance of cefaclor and related cephalosporins in the future, and (5) when to refer to allergist. The examiner will observe your response and ask follow-up questions.
π‘ Examiner instruction (interactive): This is a case of serum sickness-like reaction (SSLR) / serum sickness induced by cefaclor. The candidate must recognize the classic triad: fever, rash (urticarial), arthralgias/arthritis, occurring 7-14 days after drug exposure. Key points: (a) distinguish true serum sickness (immune complex-mediated, low complement) from SSLR (complement normal, no vasculitis), (b) cefaclor is a common cause, (c) stop the offending drug immediately, (d) treat symptomatically with antihistamines and NSAIDs; use corticosteroids for severe cases, (e) avoid future use of cefaclor and possibly related cephalosporins, and (f) differentiate from Kawasaki disease (oral changes, conjunctivitis, desquamation) and JIA (chronic course, no drug exposure).
π Examiner Questions (interactive) β Click to reveal model answers
β Q1 (Examiner): βWhat is the most likely diagnosis? Describe the classic triad of serum sickness/serum sickness-like reaction.β
β Candidate's answer:
β’ Diagnosis:Serum sickness-like reaction (SSLR) β most likely, though serum sickness is a possibility.
β’ Classic triad (3 cardinal features):
1οΈβ£ Fever β usually 38-39Β°C, occurring 7-14 days after drug exposure.
2οΈβ£ Rash β typically urticarial (hives), but can be morbilliform or erythema multiforme-like.
3οΈβ£ Arthralgias/arthritis β symmetric or asymmetric, often involving large joints (knees, ankles, elbows).
β’ Additional features: Lymphadenopathy (often generalized or cervical), myalgia, malaise, periorbital or peripheral edema.
β’ This patient has all three cardinal features (fever, urticarial rash, arthralgias) 10 days after starting cefaclor β classic for SSLR.
β Q2 (Examiner): βWhat is the difference between true serum sickness and serum sickness-like reaction (SSLR)? How would you differentiate them?β
β Candidate's answer:
β’ True serum sickness (Type III hypersensitivity):
- Caused by immune complex deposition (antigen-antibody complexes) in blood vessels and tissues.
- Associated with heterologous proteins (e.g., horse-derived antivenom, antithymocyte globulin, infliximab) and some drugs (penicillins, sulfonamides).
- Laboratory findings:Hypocomplementemia (low C3, C4), elevated ESR/CRP, possible proteinuria or hematuria (vasculitis).
- May cause vasculitis, glomerulonephritis, or carditis (rare).
β’ Serum sickness-like reaction (SSLR):
- Clinically similar to serum sickness but no immune complexes and normal complement levels.
- More common in children.
- Common triggers:Cefaclor (most common), other cephalosporins, penicillins, sulfonamides, minocycline, bupropion.
- No vasculitis or organ involvement β limited to skin, joints, lymph nodes.
- Laboratory findings: Normal complement (C3, C4), elevated ESR/CRP, no proteinuria/hematuria.
β’ This patient likely has SSLR (cefaclor is a classic trigger), but complement testing would differentiate.
β Q3 (Examiner): βExplain the pathophysiology of serum sickness and serum sickness-like reactions. Why does it occur 7-14 days after drug exposure?β
β Candidate's answer:
β’ True serum sickness (Type III hypersensitivity):
- Days 1-7: Drug or foreign protein acts as an antigen β B cells produce specific IgG/IgM antibodies.
- Day 7-14: Antigen-antibody complexes form in slight antigen excess β complexes deposit in vessel walls, joints, kidneys, skin.
- Complement activation β recruitment of neutrophils β tissue damage (vasculitis, arthritis, urticaria).
β’ Serum sickness-like reaction (SSLR):
- Mechanism is not fully understood, but NO immune complexes or complement activation.
- May be due to direct T-cell activation or drug-induced cytokine release.
- Clinically identical to serum sickness but without vasculitis or organ damage.
β’ Why 7-14 days? Time required for primary immune response (antibody production) after first exposure to the antigen. If the patient was previously sensitized, reaction can occur within 1-3 days (accelerated).
β Q4 (Examiner): βWhat is the differential diagnosis for a child presenting with fever, rash, and arthralgias after antibiotic exposure?β
β Candidate's answer:
β’ Serum sickness / serum sickness-like reaction β most likely.
β’ Kawasaki disease: Fever >5 days, bilateral conjunctival injection, oral mucosal changes (strawberry tongue, fissured lips), polymorphous rash, cervical lymphadenopathy (>1.5 cm), extremity changes (edema, desquamation). This patient has NO oral or conjunctival changes.
β’ Juvenile idiopathic arthritis (JIA), systemic onset (Still disease): Daily high fevers (>39Β°C) with quotidian pattern, salmon-pink rash, arthralgias/arthritis. No drug exposure history; chronic course.
β’ Urticarial vasculitis: Urticarial lesions lasting >24 hours, with palpable purpura, burning sensation (not itching), possible hypocomplementemia. Skin biopsy shows leukocytoclastic vasculitis.
β’ Viral exanthem (e.g., EBV, parvovirus B19, enterovirus): Often associated with pharyngitis, coryza, or other viral symptoms; no temporal relationship with drug.
β’ Drug reaction with eosinophilia and systemic symptoms (DRESS): Fever, rash, eosinophilia, atypical lymphocytosis, organ involvement (hepatitis, nephritis). Onset 2-8 weeks after drug start.
β’ This patient's history (cefaclor exposure, onset day 8-10, urticarial rash, arthralgias, no mucosal changes) strongly favors SSLR.
β Q5 (Examiner): βWhat is your immediate management for this child? Which medication should be stopped?β
β Candidate's answer:
β’ Immediate step: Discontinue the offending drug β cefaclor (and any other cephalosporin or Ξ²-lactam antibiotic).
β’ Symptomatic treatment:
1οΈβ£ Antihistamines for urticaria and pruritus:
- Oral cetirizine (0.25 mg/kg, max 10 mg) or diphenhydramine (1 mg/kg, max 50 mg).
2οΈβ£ NSAIDs for arthralgias/fever:
- Ibuprofen (10 mg/kg/dose q6-8h) or naproxen.
3οΈβ£ Cool compresses for rash.
β’ If symptoms are severe (high fever, significant joint swelling, severe rash):
- Oral corticosteroids (prednisone 1-2 mg/kg/day for 3-7 days, then taper).
β’ Monitoring: Observe for progression (though most cases resolve within 1-2 weeks after drug discontinuation).
β’ Do NOT restart cefaclor or give another cephalosporin unless allergy testing is performed.
β Q6 (Examiner): βWhat laboratory investigations would you order to confirm the diagnosis and rule out other conditions?β
β Candidate's answer:
β’ To support SSLR and rule out more serious conditions:
1οΈβ£ Complete blood count (CBC) with differential: May show leukocytosis, normal or elevated eosinophils (not as high as in DRESS).
2οΈβ£ Inflammatory markers: ESR, CRP β elevated (non-specific).
3οΈβ£ Complement levels (C3, C4):Normal in SSLR; low in true serum sickness and some autoimmune conditions.
4οΈβ£ Urinalysis: To rule out glomerulonephritis (proteinuria, hematuria β would indicate true serum sickness).
5οΈβ£ Liver and renal function tests: To rule out DRESS or systemic involvement.
6οΈβ£ Antinuclear antibody (ANA), rheumatoid factor (RF): To rule out JIA or SLE.
7οΈβ£ If Kawasaki disease is suspected: Echocardiogram (for coronary artery dilation).
β’ This patient likely has normal complement and urinalysis (SSLR).
β Q7 (Examiner): βWhen would you use corticosteroids in a child with serum sickness-like reaction? What dose and duration?β
β Candidate's answer:
β’ Corticosteroids are NOT routinely required for mild SSLR. They are reserved for severe cases with:
- High fever (>39Β°C) not responding to NSAIDs.
- Severe, debilitating arthralgias or arthritis (inability to walk).
- Extensive, painful urticaria.
- Significant lymphadenopathy or edema.
- True serum sickness with vasculitis or renal involvement.
β’ Dose:Prednisone 1-2 mg/kg/day (max 60 mg/day) orally once daily.
β’ Duration:3-7 days (short course). Tapering may not be necessary for short courses (<7 days), but can be tapered over 1-2 weeks if symptoms were severe.
β’ Monitor for improvement within 24-48 hours. If no improvement, reconsider diagnosis.
β’ This patient (mild symptoms) does not need steroids β treat with antihistamines and NSAIDs.
β Q8 (Examiner): βIf this child has a reaction to cefaclor, can he receive other cephalosporins or penicillins in the future?β
β Candidate's answer:
β’ SSLR to cefaclor is not a contraindication to all cephalosporins or penicillins, but caution is advised.
β’ Cefaclor is a second-generation cephalosporin. There is low cross-reactivity between different generations of cephalosporins for SSLR.
β’ However, if the reaction was severe (e.g., Stevens-Johnson syndrome, DRESS), all cephalosporins should be avoided.
β’ Penicillins: There is no cross-reactivity between cefaclor and penicillins for SSLR (different chemical structure). However, if the patient has a true IgE-mediated penicillin allergy, cross-reactivity with cephalosporins is <2%.
β’ Recommendation:
- Avoid cefaclor specifically.
- Other cephalosporins may be used if clinically necessary, but under observation (graded challenge in a controlled setting if high-risk).
- Penicillins are likely safe (no cross-reactivity for SSLR).
- Refer to allergist for drug allergy testing and guidance.
β Q9 (Examiner): βWhat is the expected clinical course and prognosis for a child with SSLR?β
β Candidate's answer:
β’ Excellent prognosis with prompt discontinuation of the offending drug.
β’ Clinical course:
- After stopping the drug, symptoms usually begin to improve within 24-48 hours.
- Rash and arthralgias resolve over 3-7 days.
- Fever resolves within 1-3 days.
- Complete resolution typically within 1-2 weeks.
β’ Without discontinuation of the drug, symptoms may persist or worsen.
β’ No long-term sequelae β SSLR does not cause chronic arthritis or autoimmune disease.
β’ Recurrence: If the same drug is taken again, the reaction can recur, often more rapidly (within 1-3 days).
β’ This patient should recover completely within 1 week after stopping cefaclor.
β Q10 (Examiner): βShould this child be referred to an allergist? Why?β
β Candidate's answer:
β’ Yes, referral to an allergist is recommended.
β’ Reasons:
1οΈβ£ Confirmation of the diagnosis β differentiate from true serum sickness, DRESS, or other drug hypersensitivity reactions.
2οΈβ£ Testing for drug allergy: Skin testing for cephalosporins may be performed (though not standardized for cefaclor).
3οΈβ£ Guidance on future antibiotic use: Determine whether other cephalosporins or penicillins can be safely used.
4οΈβ£ Drug challenge: If an alternative Ξ²-lactam is needed, a graded challenge may be performed under supervision.
5οΈβ£ Education for the family: Clear documentation of the reaction and future avoidance strategies.
6οΈβ£ Medical alert bracelet: May be recommended for severe reactions.
- This child should be referred to an allergist for evaluation and management.
β Q11 (Examiner): βWhich drugs are most commonly associated with serum sickness-like reactions in children?β
β Candidate's answer:
β’ Cefaclor (oral cephalosporin) β most common cause of SSLR in children.
β’ Other antibiotics: Penicillins (amoxicillin, ampicillin), sulfonamides (trimethoprim-sulfamethoxazole), minocycline.
β’ Anticonvulsants: Phenytoin, carbamazepine, lamotrigine.
β’ NSAIDs and aspirin β less common.
β’ Biologics: Infliximab, rituximab, omalizumab (true serum sickness).
β’ Vaccines: Rare (e.g., tetanus toxoid, rabies vaccine).
β’ This patient's reaction to cefaclor is classic.
β Q12 (Examiner): βHow would you differentiate SSLR from DRESS (drug reaction with eosinophilia and systemic symptoms)?β
β Candidate's answer:
β’ SSLR:
- Onset: 7-14 days after drug start.
- Rash: Urticarial (hives) β pruritic.
- Fever, arthralgias, lymphadenopathy.
- No internal organ involvement (no hepatitis, nephritis, pneumonitis).
- Eosinophilia: Usually absent or mild.
- Atypical lymphocytes: Absent.
- Prognosis: Excellent, resolves quickly after drug cessation.
β’ DRESS (drug reaction with eosinophilia and systemic symptoms):
- Onset: 2-8 weeks (delayed).
- Rash: Morbilliform or erythroderma, may progress to exfoliative dermatitis.
- Fever, facial edema, lymphadenopathy.
- Internal organ involvement: Hepatitis (most common), nephritis, pneumonitis, myocarditis.
- Eosinophilia (>1500/ΞΌL), atypical lymphocytes.
- Severe, potentially fatal (mortality 5-10%).
- Can reactivate herpesviruses (HHV-6, EBV, CMV).
- Treatment: Systemic corticosteroids, sometimes IVIG.
β’ This patient (urticarial rash, no organ involvement) is consistent with SSLR, not DRESS.
β Q13 (Examiner): βHow will you counsel the mother who is worried that her son had a severe reaction to the antibiotic?β
β Candidate's structured answer:
β’ βYour son had a reaction called serum sickness-like reaction. It is a type of allergic reaction to the antibiotic cefaclor. It is not anaphylaxis (no breathing problems), but it can be uncomfortable.β
β’ βThe good news is that this reaction is temporary. Now that we have stopped the antibiotic, he should start feeling better in 1-2 days. The rash and joint pain will go away completely within a week.β
β’ βHe will need to avoid cefaclor and possibly other cephalosporin antibiotics in the future. If he needs antibiotics again, tell any doctor about this reaction. Penicillins (like amoxicillin) are likely safe, but we will refer you to an allergist to be sure.β
β’ βThis was not a life-threatening reaction, but it was uncomfortable. We will treat his symptoms with antihistamines for the itching and ibuprofen for the joint pain.β
β’ βIf his symptoms worsen (high fever, trouble breathing, swelling of the face or throat), bring him back immediately. But that is unlikely.β
β’ βYou did the right thing by bringing him in. We will take good care of him, and he will be fine.β
β Q14 (Examiner): βWhat should be documented in this childβs medical record? What precautions should be taken for future antibiotic prescriptions?β
β Candidate's answer:
β’ Documentation in medical record:
- Clear allergy label: βCefaclor β serum sickness-like reaction (fever, urticaria, arthralgias).β
- Date of reaction, symptoms, duration of treatment.
- Avoid cefaclor specifically; caution with other cephalosporins.
β’ Precautions for future antibiotics:
1οΈβ£ Avoid cefaclor.
2οΈβ£ Other cephalosporins may be used with caution (if clinically necessary) β consider graded challenge under allergist supervision.
3οΈβ£ Penicillins (amoxicillin, etc.) are likely safe (no cross-reactivity for SSLR).
4οΈβ£ If the child has a severe infection requiring a cephalosporin (e.g., meningitis), consult allergist for skin testing and possible desensitization.
5οΈβ£ Alert family to inform all healthcare providers about this reaction.
- This child should have an allergy bracelet only if recommended by an allergist.
π£οΈ Examiner's probing / high-yield points (Serum Sickness-Like Reaction):
β’ "What is the classic triad?" β Fever, urticarial rash, arthralgias/arthritis (7-14 days after drug exposure).
β’ "What is the most common drug causing SSLR in children?" β Cefaclor.
β’ "What is the difference between true serum sickness and SSLR?" β True serum sickness: immune complexes, hypocomplementemia, vasculitis. SSLR: normal complement, no vasculitis.
β’ "What is the first step in management?" β Discontinue the offending drug.
β’ "Do you need corticosteroids for mild SSLR?" β No β antihistamines and NSAIDs are sufficient.
β’ "What is the differential diagnosis?" β Kawasaki disease, JIA, DRESS, urticarial vasculitis, viral exanthem.
β’ "Can the child receive penicillins in the future?" β Likely yes (no cross-reactivity for SSLR).
β’ "What is the prognosis?" β Excellent; complete resolution within 1-2 weeks.
π Definition Serum sickness: Type III hypersensitivity (immune complex deposition). SSLR: clinically similar but no immune complexes, normal complement. Classic triad: fever, urticarial rash, arthralgias/arthritis.
π Epidemiology & Triggers Most common in children. Cefaclor is the most common drug trigger. Also penicillins, sulfonamides, minocycline, anticonvulsants, biologics. Onset 7-14 days after first exposure (1-3 days if re-exposed).
π Diagnosis Clinical (history of drug exposure + triad). Labs: CBC (leukocytosis), ESR/CRP elevated, complement (C3, C4) normal in SSLR (low in true serum sickness). UA normal (no proteinuria/hematuria).
π Management Discontinue offending drug. Antihistamines (cetirizine, diphenhydramine) for rash. NSAIDs (ibuprofen, naproxen) for arthralgias. Corticosteroids (prednisone 1-2 mg/kg/day) for severe cases.
π Prognosis & Prevention Excellent prognosis β resolves in 1-2 weeks. Avoid culprit drug. Penicillins are likely safe. Refer to allergist for testing and guidance on future antibiotic use.
β High-yield pearls for TOACS (Serum Sickness / SSLR):
β’ Classic triad: fever + urticarial rash + arthralgias (7-14 days after drug).
β’ Cefaclor is the most common cause in children.
β’ First step: Discontinue the offending drug.
β’ Treat with antihistamines + NSAIDs; reserve steroids for severe cases.
β’ Complement (C3, C4) is NORMAL in SSLR (low in true serum sickness).
β’ Differential: Kawasaki disease (oral/conjunctival changes), JIA (chronic), DRESS (organ involvement, eosinophilia).
β’ Penicillins are likely safe β no cross-reactivity for SSLR.
π£οΈ Candidate's role-play & examiner feedback
π¬ To the candidate (roleβplay): You will be asked the 14 questions from the Examiner Q&A tab. This station tests knowledge of serum sickness and serum sickness-like reactions β the classic triad (fever, urticarial rash, arthralgias) occurring 7-14 days after drug exposure. The candidate must differentiate SSLR from true serum sickness (complement levels), recognize cefaclor as the most common trigger, discontinue the drug, treat symptomatically with antihistamines and NSAIDs, and use corticosteroids only for severe cases. Also discuss differential diagnosis (Kawasaki disease, JIA, DRESS) and future antibiotic precautions (penicillins likely safe). Provide empathetic counseling to the mother β reassure her that the reaction is temporary and not life-threatening.
β Counsels mother appropriately (reassures that condition is temporary, explains future antibiotic precautions, refers to allergist)
π Key references: Nelson Textbook of Pediatrics 22e (Chapter 191 β Serum Sickness), American Academy of Allergy, Asthma & Immunology guidelines on drug hypersensitivity, CPSP protocols for adverse drug reactions.